Breaking News Instant updates and real-time market news.

MRK

Merck

$61.66

-0.27 (-0.44%)

06:47
10/13/16
10/13
06:47
10/13/16
06:47

Merck upgraded to Buy from Neutral at BofA/Merrill

BofA/Merrill analyst Colin Bristow upgraded Merck to Buy and raised its price target to $70 from $57 to reflect its opportunity in first line lung cancer. Bristow significantly raised his Keytruda sales estmate to 7.5B from $5.5B following Merck's first line lung cancer data presentations at ESMO over the weekend and feedback from experts. He expects Keytruda to receive early approval/launch in first line NSCLC from the December 24 PDUFA and to become the standard of care in the identified label and further upside from chemo combo.

  • 25

    Oct

  • 06

    Nov

MRK Merck
$61.66

-0.27 (-0.44%)

10/10/16
LEER
10/10/16
NO CHANGE
LEER
Outperform
Leerink sees Bristol-Myers sliding after Merck's 'spectacular' Keytruda data
Leerink analyst Seamus Fernandez said Bristol-Myers' (BMY) Checkmate-026 data presented at the European Society of Medical Oncology meeting was disappointing, noting there was no signal of benefit on progression-free survival or overall survival and only "modest differentiation" on response rate in the 88 patients with PDL1 biomarker positivity greater than or equal to 50%. Meanwhile, Merck (MRK) presented "spectacular" data for Keytruda monotherapy at the meeting, said Fernandez, who expects Bristol shares to be down "significantly" today in light of the meeting presentations. The analyst, who still thinks Bristol has a significant opportunity to compete with Merck's Keytruda in the PDL1 high portion of the market, keeps an Outperform rating on Bristol shares, which are down nearly 6% in pre-market trading.
10/10/16
BMOC
10/10/16
NO CHANGE
BMOC
Merck should strengthen leadership in first line NSCLC, says BMO Capital
BMO Capital analyst Alex Arfaei says that upcoming data should strengthen Merck's (MRK) lead in 1L NSCLC. The analyst adds that the data could support off-label use of Merck's Keytruda in additional 1L NSCLC patients, and he says that the data "should be negative" for Bristol-Myers' (BMY) Opdivo drug. Arfaei keeps an Outperform rating on Merck and a Market Perform rating on Bristol-Myers.
10/10/16
LEER
10/10/16
NO CHANGE
LEER
Market Perform
Merck 'steals the show' at ESMO with Keytruda data, says Leerink
Leerink analyst Seamus Fernandez said Merck (MRK) stole the show at ESMO with its Keytruda data and he continues to think the company will dominate first line lung cancer treatment for years to come in patients with 50%+ PDL1 expression. Additionally, he expects Merck to gain additional traction in the overall market, noting that confirmation that Keytruda is benefiting patients when combined with Alimta/carboplatin with Alimta maintenance raises the possibility Merck could compete broadly in the overall non-squamous patient population. However, Fernandez keeps a Market Perform rating on Merck, as he thinks its current valuation largely reflects improved growth prospects through 2020.
10/10/16
JMPS
10/10/16
NO CHANGE
JMPS
Incyte treatment looking 'promising,' says JMP Securities
After reviewing recent data, JMP Securities analyst Liisa Bayko says that the combination of Incyte's (INCY) Epacadostat plus Merck's (MRK) Keytruda is "emerging as a promising treatment, potentially even best in class." The analyst says that the progression free survival rate of the combination in melanoma patients "is emerging to be quite competitive," while the efficacy rate in other solid tumors "seemed encouraging." The analyst raised her price target on Incyte to $110 from $100 and keeps an Outperform rating on the stock.

TODAY'S FREE FLY STORIES

BOCH

Bank of Commerce Holdings

$11.05

0.1 (0.91%)

11:01
04/24/17
04/24
11:01
04/24/17
11:01
Hot Stocks
Bank of Commerce Holdings to relocate headquarters to Sacramento from Redding »

Randall S. Eslick,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WHR

Whirlpool

$174.98

3.47 (2.02%)

11:01
04/24/17
04/24
11:01
04/24/17
11:01
Technical Analysis
Whirlpool technical comments before earnings »

The shares have been…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 04

    May

SBH

Sally Beauty

$19.27

-0.425 (-2.16%)

, SMRT

Stein Mart

10:57
04/24/17
04/24
10:57
04/24/17
10:57
Hot Stocks
Sally Beauty slides after downgrade as KeyBanc sees 'hairy' retail story »

Shares of Sally Beauty…

SBH

Sally Beauty

$19.27

-0.425 (-2.16%)

SMRT

Stein Mart

ULTA

Ulta Beauty

$279.50

0.77 (0.28%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

BX

Blackstone

$30.35

0.07 (0.23%)

10:56
04/24/17
04/24
10:56
04/24/17
10:56
Options
Blackstone put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:55
04/24/17
04/24
10:55
04/24/17
10:55
General news
Treasury Action: Treasuries were unaffected by Dallas Fed beat »

Treasury Action:…

KURA

Kura Oncology

10:52
04/24/17
04/24
10:52
04/24/17
10:52
Conference/Events
Kura Oncology management to meet with JMP Securities »

Meeting to be held on the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

10:50
04/24/17
04/24
10:50
04/24/17
10:50
General news
U.S. Dallas Fed manufacturing index dipped 0.1 point to 16.8 in April »

U.S. Dallas Fed…

DWCH

Datawatch

$9.25

0.85 (10.12%)

10:49
04/24/17
04/24
10:49
04/24/17
10:49
Conference/Events
Datawatch management to meet with Craig Hallum »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

BGG

Briggs & Stratton

$23.94

0.44 (1.87%)

10:46
04/24/17
04/24
10:46
04/24/17
10:46
Conference/Events
Briggs & Stratton management to meet with Sidoti »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

10:45
04/24/17
04/24
10:45
04/24/17
10:45
General news
Breaking General news story  »

4-Week Bill Announcement…

AKS

AK Steel

$6.93

0.2083 (3.10%)

, STLD

Steel Dynamics

$35.37

0.46 (1.32%)

10:44
04/24/17
04/24
10:44
04/24/17
10:44
Hot Stocks
Analyst upgrades steel stocks on signs of rebounding demand »

Macquarie upgraded…

AKS

AK Steel

$6.93

0.2083 (3.10%)

STLD

Steel Dynamics

$35.37

0.46 (1.32%)

NUE

Nucor

$60.99

0.99 (1.65%)

X

U.S. Steel

$31.14

0.72 (2.37%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 26

    Apr

  • 25

    May

X

U.S. Steel

$31.10

0.68 (2.24%)

10:41
04/24/17
04/24
10:41
04/24/17
10:41
Options
US Steel sees a bullish option play ahead of earnings »

US Steel sees a bullish…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

PZRX

PhaseRx

$1.24

-0.01 (-0.80%)

10:40
04/24/17
04/24
10:40
04/24/17
10:40
Hot Stocks
PhaseRx receives EC orphan medicinal product designation »

PhaseRx's modified…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HLF

Herbalife

$61.20

1.215 (2.03%)

, WGO

Winnebago

$27.00

0.75 (2.86%)

10:38
04/24/17
04/24
10:38
04/24/17
10:38
Initiation
On The Fly: Top five analyst initiations »

Catch up on today's…click here.

HLF

Herbalife

$61.20

1.215 (2.03%)

WGO

Winnebago

$27.00

0.75 (2.86%)

VC

Visteon

$97.32

0.3 (0.31%)

RGEN

Repligen

$35.06

-0.78 (-2.18%)

RBA

Ritchie Bros.

$31.48

0.74 (2.41%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 04

    May

  • 04

    May

  • 05

    May

  • 30

    May

  • 06

    Jun

  • 08

    Jun

DIS

Disney

$114.80

0.36 (0.31%)

, GRPN

Groupon

$3.88

-0.02 (-0.51%)

10:38
04/24/17
04/24
10:38
04/24/17
10:38
Downgrade
On The Fly: Top five analyst downgrades »

Catch up on today's…click here.

DIS

Disney

$114.80

0.36 (0.31%)

GRPN

Groupon

$3.88

-0.02 (-0.51%)

GWW

Grainger

$192.42

-2.735 (-1.40%)

BAC

Bank of America

$23.67

0.955 (4.21%)

DFT

DuPont Fabros

$49.76

-1.44 (-2.81%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 26

    Apr

  • 27

    Apr

  • 03

    May

  • 09

    May

  • 09

    May

  • 31

    May

  • 06

    Jun

  • 19

    Jul

  • 17

    Oct

  • 24

    Jan

SWK

Stanley Black & Decker

$138.17

0.61 (0.44%)

, KEY

KeyCorp

$18.77

0.615 (3.39%)

10:38
04/24/17
04/24
10:38
04/24/17
10:38
Upgrade
On The Fly: Top five analyst upgrades »

Catch up on today's…click here.

SWK

Stanley Black & Decker

$138.17

0.61 (0.44%)

KEY

KeyCorp

$18.77

0.615 (3.39%)

SONC

Sonic

$24.91

0.63 (2.59%)

TRV

Travelers

$120.96

1.86 (1.56%)

WING

Wingstop

$28.27

0.175 (0.62%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    May

  • 09

    May

  • 24

    May

  • 31

    May

  • 20

    Jun

B

Barnes Group

$51.83

0.4 (0.78%)

10:37
04/24/17
04/24
10:37
04/24/17
10:37
Downgrade
Barnes Group rating change  »

Barnes Group downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

  • 09

    May

KMB

Kimberly-Clark

$129.49

-0.47 (-0.36%)

10:35
04/24/17
04/24
10:35
04/24/17
10:35
Hot Stocks
Kimberly-Clark says 'don't play too much on speculation process' for M&A »

Regarding the current…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 31

    May

10:33
04/24/17
04/24
10:33
04/24/17
10:33
General news
Dallas Fed Mfg Survey General Activity Index data reported »

April Dallas Fed Mfg…

AMP

Ameriprise

$132.30

3.86 (3.01%)

10:33
04/24/17
04/24
10:33
04/24/17
10:33
Hot Stocks
Ameriprise announces agreement to acquire Investment Professionals »

Ameriprise Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 26

    Apr

  • 26

    Apr

BAC

Bank of America

$23.70

0.99 (4.36%)

10:31
04/24/17
04/24
10:31
04/24/17
10:31
Options
Heavy trading in BofA calls as shares rally Monday »

Heavy trading in BofA…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 09

    May

  • 31

    May

  • 06

    Jun

NBL

Noble Energy

$34.17

0.02 (0.06%)

, CWEI

Clayton Williams

$133.00

0.1 (0.08%)

10:25
04/24/17
04/24
10:25
04/24/17
10:25
Conference/Events
Clayton Williams to host special shareholder meeting »

Special Shareholder…

NBL

Noble Energy

$34.17

0.02 (0.06%)

CWEI

Clayton Williams

$133.00

0.1 (0.08%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 25

    Apr

  • 02

    May

AKTX

Akari Therapeutics

$20.50

4.13 (25.23%)

10:25
04/24/17
04/24
10:25
04/24/17
10:25
Conference/Events
Akari Therapeutics to host research and development day »

Research and Development…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

MSFT

Microsoft

$66.40

0.9 (1.37%)

10:21
04/24/17
04/24
10:21
04/24/17
10:21
Options
$4.2M premium block in Microsoft ahead of earnings »

$4.2M premium block in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 02

    May

  • 09

    May

10:20
04/24/17
04/24
10:20
04/24/17
10:20
General news
FX Action: USD-JPY »

FX Action: USD-JPY has so…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.